Hemogenyx Pharmaceuticals PLC Total Liabilities

Latest as of June 2025: GBX3.65 Million GBX ≈ $443.82 USD

Hemogenyx Pharmaceuticals PLC total liabilities. Based on the latest financial reports, Hemogenyx Pharmaceuticals PLC (HEMO) has total liabilities worth GBX3.65 Million GBX (≈ $443.82 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Hemogenyx Pharmaceuticals PLC defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Hemogenyx Pharmaceuticals PLC (2015–2024)

Total liabilities of Hemogenyx Pharmaceuticals PLC from 2015 to 2024. This chart illustrates how Hemogenyx Pharmaceuticals PLC's total liabilities have evolved over time, based on quarterly financial data.

Hemogenyx Pharmaceuticals PLC Competitors by Total Liabilities

The table below lists competitors of Hemogenyx Pharmaceuticals PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Global Gas Corporation NASDAQ:HGAS	USA	$380.35K
SU Group Holdings Limited Ordinary Shares NASDAQ:SUGP	USA	$34.45 Million
LIVE MOTION GAMES ZY -10 F:4YM	Germany	€3.45 Million
Metgasco Ltd AU:MEL	Australia	AU$13.81 Million
SysGroup PLC LSE:SYS	UK	GBX14.56 Million
Nevada Zinc Corp V:NZN	Canada	CA$630.72K

Liability Composition Analysis (2015–2024)

This chart breaks down Hemogenyx Pharmaceuticals PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Hemogenyx Pharmaceuticals PLC.

Liquidity & Leverage Metrics

Hemogenyx Pharmaceuticals PLC Total Liabilities Ratios Explained

Hemogenyx Pharmaceuticals PLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.43	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-7.29	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hemogenyx Pharmaceuticals PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hemogenyx Pharmaceuticals PLC (2015–2024)

The table below shows the annual total liabilities of Hemogenyx Pharmaceuticals PLC from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX3.36 Million ≈ $408.58	+1.00%
2023-12-31	GBX3.32 Million ≈ $404.54	-13.62%
2022-12-31	GBX3.85 Million ≈ $468.32	+990.88%
2021-12-31	GBX352.84K ≈ $42.93	-80.28%
2020-12-31	GBX1.79 Million ≈ $217.66	+27.88%
2019-12-31	GBX1.40 Million ≈ $170.21	+4.36%
2018-12-31	GBX1.34 Million ≈ $163.09	+408.35%
2017-12-31	GBX263.69K ≈ $32.08	+83.50%
2016-12-31	GBX143.69K ≈ $17.48	-41.78%
2015-12-31	GBX246.83K ≈ $30.03	--

About Hemogenyx Pharmaceuticals PLC

LSE:HEMO UK Biotechnology

Market Cap

$371.82K

GBX3.06 Billion GBX

Market Cap Rank

#31165 Global

#956 in UK

Share Price

GBX570.00

Change (1 day)

-2.56%

52-Week Range

GBX412.50 - GBX1140.00

All Time High

GBX1545.00